These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 3722135)
21. Haloperidol and reduced haloperidol plasma levels in selected schizophrenic patients. Ereshefsky L; Davis CM; Harrington CA; Jann MW; Browning JL; Saklad SR; Burch NR J Clin Psychopharmacol; 1984 Jun; 4(3):138-42. PubMed ID: 6736273 [TBL] [Abstract][Full Text] [Related]
22. A controlled double-blind study of haloperidol versus thioridazine in the treatment of restless mentally subnormal patients. Serum levels and clinical effects. Väisänen K; Rimón R; Räisänen P; Viukari M Acta Psychiatr Belg; 1979; 79(6):673-85. PubMed ID: 554446 [TBL] [Abstract][Full Text] [Related]
23. [Comparison of the therapeutic effects between haloperidol and insulin coma in schizophrenia and optimal blood levels of haloperidol]. Shu L Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1987 Feb; 20(1):43-8. PubMed ID: 3304870 [No Abstract] [Full Text] [Related]
24. Absence of relationship of serum haloperidol concentration and clinical response in chronic schizophrenia: a fixed-dose study. Bigelow LB; Kirch DG; Braun T; Korpi ER; Wagner RL; Zalcman S; Wyatt RJ Psychopharmacol Bull; 1985; 21(1):66-8. PubMed ID: 3983341 [No Abstract] [Full Text] [Related]
25. Intensive treatment with haloperidol of treatment-resistant chronic schizophrenic patients. Hollister LE; Kim DY Am J Psychiatry; 1982 Nov; 139(11):1466-8. PubMed ID: 7137396 [TBL] [Abstract][Full Text] [Related]
26. The effects of classic antipsychotic haloperidol plus the extract of ginkgo biloba on superoxide dismutase in patients with chronic refractory schizophrenia. Zhou D; Zhang X; Su J; Nan Z; Cui Y; Liu J; Guan Z; Zhang P; Shen Y Chin Med J (Engl); 1999 Dec; 112(12):1093-6. PubMed ID: 11721446 [TBL] [Abstract][Full Text] [Related]